Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FIBRINOGEN HUMAN\THROMBIN HUMAN for Supportive care: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where FIBRINOGEN HUMAN\THROMBIN HUMAN was used for Supportive care.

Most Reported Side Effects for FIBRINOGEN HUMAN\THROMBIN HUMAN

Side Effect Reports % Deaths Hosp.
Off label use 225 22.4% 11 30
Drug ineffective 132 13.2% 5 14
Product use in unapproved indication 95 9.5% 3 10
Cerebrospinal fluid leakage 57 5.7% 2 23
Haemorrhage 50 5.0% 8 3
Seroma 49 4.9% 0 5
Drug ineffective for unapproved indication 42 4.2% 3 7
Product physical consistency issue 31 3.1% 0 0
Wound infection 29 2.9% 0 3
Post procedural complication 26 2.6% 1 8
Haematoma 23 2.3% 1 2
Graft complication 22 2.2% 0 0
Procedural complication 19 1.9% 2 5
Product adhesion issue 19 1.9% 0 2
Product quality issue 19 1.9% 1 3

Other Indications for FIBRINOGEN HUMAN\THROMBIN HUMAN

Tissue sealing (226) Haemostasis (171) Product used for unknown indication (146) Off label use (39) Prophylaxis (33) Hernia repair (28) Surgery (26) Pterygium operation (25) Abdominal hernia repair (19) Cerebrospinal fluid leakage (19)

Other Drugs Used for Supportive care

ONDANSETRON (164) DEXAMETHASONE (154) APREPITANT (132) PEGFILGRASTIM (120) FILGRASTIM (93) GRANULOCYTE COLONY-STIMULATING FACTOR NOS (36) ALLOPURINOL (34) METHOTREXATE (34) PACLITAXEL (34) DOMPERIDONE (32)

Related Pages

FIBRINOGEN HUMAN\THROMBIN HUMAN Full Profile All Supportive care Drugs FIBRINOGEN HUMAN\THROMBIN HUMAN Demographics FIBRINOGEN HUMAN\THROMBIN HUMAN Timeline